Maker Gives Up on Alzheimer's Drug

Approval process, pricing, and murky benefits contributed to Aduhelm's failure on the market
Posted Jan 31, 2024 7:05 PM CST
More News: People Injured In Shooting Near Chief... | Michelle Obama Had Another Message To... | Bill Gates Has Covid.Html | Covington Teen To Speak At Rnc.Html | In Swift Trial Celebrity Chef Mario B...